The Power of GENETICS
Extending the power of DNA into small molecule drug generation
Empress makes small molecule drug discovery more predictable and efficient by accessing superior drug starting points from chemistry encoded in DNA.
A vast and untapped opportunity
The solution to faster drug discovery is inside of us
The amount of genomic material in the metagenome that encodes instructions for the biosynthesis of small molecules is equivalent to ~50% of the human genome.
Until now, this universe has never been systematically explored, mapped to therapeutic opportunities, and mined for new medicines.
From DNA to chemistry
Genetic code programs cells in the human body to produce chemistry in the form of metabolites.
Advances in genomics, AI, and synthetic biology now allow us to “read” this code sourced from patient samples and systematically identify, decode, and use these biosynthetic instructions to make small molecule drugs fast.
Co-evolved with biology
The molecules made inside our bodies today are the sum result of innumerable evolutionary experiments across millennia.
Biosynthetic DNA reveals instructions for making potent, selective chemistries that are human compatible and important for maintaining health and treating or preventing disease.
DNA encodes proteins that synthesize small molecules
The biosynthetic metagenome is equivalent to 50 percent of the human genome.
DNA encodes proteins, specifically enzymes, that make or modify small molecules.
Countless small molecules made and tested by Nature in the human body to maintain human health.
Created by co-evolution, co-validated by life
We sample from millions of small molecules that have co-evolved to be made, modified, and play important roles within the human body.
We leverage genetics to discover Co-Evolved MedicinesTM as well as their mechanisms and disease relevance.
Broad therapeutic potential
Comparing patient data from health and disease allows us to map chemistry to therapeutic potential. These molecules can be found throughout the body, showing the potential to address a wide range of diseases.